The short version of Aib substitution fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-01-22 and is reviewed periodically as new material appears.
Receptor activation raises intracellular cyclic AMP through Gs coupling, which promotes glucose-dependent insulin release and suppresses glucagon secretion when blood glucose is elevated. Effects outside the pancreas include slower gastric emptying and altered appetite signalling in the hypothalamus and hindbrain. The relative contribution of each tissue to overall metabolic outcomes remains an area of active investigation. Central mechanisms in particular are inferred mainly from animal models and indirect human measures rather than direct observation.
Serum protein binding dominates the pharmacokinetic profile. The attached chain associates strongly with albumin, shielding the peptide from enzymatic attack and slowing filtration by the kidney. This interaction extends the circulation half-life to roughly one week in humans, which supports weekly administration intervals. An oral version pairs the peptide with an absorption enhancer that transiently alters gastric epithelium, permitting limited uptake; bioavailability by that route is substantially lower than by injection.
Two structural features account for the prolonged half-life of semaglutide. A modified amino acid at position 8 resists cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GLP-1. A fatty diacid side chain binds serum albumin, which limits renal clearance and protects the peptide from enzymatic breakdown. These modifications yield a plasma half-life of approximately one week in humans, allowing once-weekly administration. The relationship between plasma concentration and clinical effect varies between individuals, and sources of that variability are still being characterized.
Semaglutide is a synthetic peptide analog of glucagon-like peptide-1 (GLP-1), a hormone released from intestinal L-cells after food intake. The compound belongs to the incretin mimetic class and acts at GLP-1 receptors distributed across pancreatic, gastrointestinal, cardiovascular, and central nervous system tissues. Compared with native GLP-1, the molecule carries structural changes that extend its activity from minutes to roughly one week. It is studied for glycemic control in type 2 diabetes and for weight management, and its effects on cardiovascular and other outcomes remain active research areas.
Receptor binding triggers G protein signaling that raises intracellular cyclic AMP in pancreatic beta cells. Insulin release follows in a glucose-dependent manner, so secretion increases when blood glucose is elevated and diminishes when it is not. The same signaling suppresses glucagon release from alpha cells and slows gastric emptying, which blunts the post-meal glucose rise. In the brain, receptor activation in regions such as the arcuate nucleus is associated with reduced appetite and lower energy intake. How much each of these effects contributes to overall weight change is not fully settled.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide, GLP-1 receptor agonist | 31 amino acid residues |
| Molecular formula | C187H291N45O59 | free peptide, no counter-ion |
| Approximate mass | 4114 Da | matches theoretical value |
| Receptor target | Glucagon-like peptide-1 receptor | Gs-coupled, cyclic AMP pathway |
| Circulation half-life | About one week in humans | extended by albumin association |
Receptor activation follows the canonical Gs pathway: binding increases intracellular cyclic AMP, which promotes protein kinase A activity. In pancreatic beta cells this amplifies glucose-dependent insulin release, so secretion rises when blood glucose is high and changes little when it is low. The same signalling suppresses glucagon release from alpha cells and slows gastric emptying. Receptors in the hypothalamus and brainstem are thought to contribute to reduced appetite and lower energy intake. Which of these effects dominates clinical outcomes remains an area of active study.
Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1, a gut hormone released by intestinal L cells after food intake. The natural hormone acts on pancreatic and central receptors but is degraded within minutes by dipeptidyl peptidase-4 and other peptidases. Semaglutide belongs to the class of long-acting GLP-1 receptor agonists, a group distinguished by structural changes that slow breakdown and extend circulation time. Its development followed earlier short-acting analogues and reflects a general strategy in peptide drug design: preserve receptor activity while blocking proteolytic clearance.
The company that developed the compound filed it as a long-acting analogue, and it gained first approval in 2017 for type 2 diabetes. Later authorisations from several regulators extended the indication to chronic weight management, and the World Health Organization added the glucagon-like peptide-1 receptor agonist drug class to its model list of essential medicines in 2023. Production uses solid-phase peptide synthesis followed by side-chain conjugation and chromatographic purification. Supply constraints and cost differences across regions are well documented. Literature on long-term outcomes continues to grow, with many trials reporting surrogate endpoints rather than hard clinical endpoints.
Semaglutide is a synthetic peptide of thirty-one amino acids that shares roughly ninety-four percent sequence identity with human glucagon-like peptide-1. Two substitutions resist enzymatic cleavage by dipeptidyl peptidase-4, and a fatty diacid side chain attached through a linker promotes binding to serum albumin. That albumin binding slows renal clearance and extends the circulating half-life from minutes to approximately one week. The structural changes are well established in the published literature. Whether the same modifications affect receptor signalling bias in ways that matter clinically remains an open question.
Pharmacological activity arises from agonism at the glucagon-like peptide-1 receptor, a G protein-coupled receptor expressed in the pancreas, the gastrointestinal tract, and the brainstem. Receptor activation raises intracellular cyclic adenosine monophosphate and enhances insulin release in a glucose-dependent manner, an effect that diminishes when blood glucose concentration is low. Other effects include slowed gastric emptying and hypothalamic satiety signalling. These pathways are described well. Receptor desensitisation rates across tissues, relative to the endogenous hormone, are still under investigation, and reported findings differ between laboratories.
=== Mechanism of liver injury === The cause of the mild, transient serum enzyme elevations during imipenem-cilastatin therapy is not known. The cholestatic hepatitis attributed to imipenem-cilastatin and the carbapenems is probably immunoallergic and resembles the rare, clinically apparent liver injury that has been linked to penicillins and cephalosporins.
=== Time-reversible and stationary models === Many useful substitution models are time-reversible; in terms of the mathematics, the model does not care which sequence is the ancestor and which is the descendant so long as all other parameters (such as the number of substitutions per site that is expected between the two sequences) are held constant. When an analysis of real biological data is performed, there is generally no access to the sequences of ancestral species, only to the present-day species. However, when a model is time-reversible, which species was the ancestral species is irrelevant. Instead, the phylogenetic tree can be rooted using any of the species, re-rooted later based on new knowledge, or left unrooted. This is because there is no 'special' species, all species will eventually derive from one another with the same probability. A model is time reversible if and only if it satisfies the property (the notation is explained below)
== Genetic methods == Experimental analysis of proteins typically requires expression and purification of proteins. Expression is achieved by manipulating DNA that encodes the protein(s) of interest. Hence, protein analysis usually requires DNA methods, especially cloning. Some examples of genetic methods include conceptual translation, Site-directed mutagenesis, using a fusion protein, and matching allele with disease states. Some proteins have never been directly sequenced, however by translating codons from known mRNA sequences into amino acids by a method known as conceptual translation. (See genetic code.) Site-directed mutagenesis selectively introduces mutations that change the structure of a protein. The function of parts of proteins can be better understood by studying the change in phenotype as a result of this change. Fusion proteins are made by inserting protein tags, such as the His-tag, to produce a modified protein that is easier to track. An example of this would be GFP-Snf2H which consists of a protein bound to a green fluorescent protein to form a hybrid protein. By analyzing DNA alleles can be identified as being associated with disease states, such as in calculation of LOD scores.
The Essendon Football Club, nicknamed the Bombers or colloquially the Dons, is a professional Australian rules football club that plays in the Australian Football League (AFL), the game's premier competition. Formed by the McCracken family in their Ascot Vale home in 1872, the club played its first recorded game in 1873. From 1878 until 1896, the club played in the Victorian Football Association (VFA), where it won four consecutive premierships between 1891 and 1894. In 1896, Essendon joined seven other clubs to form the breakaway Victorian Football League (known as the AFL since 1990), winning the inaugural VFL premiership in 1897. Headquartered at Windy Hill from 1922 to 2013, the club moved to The Hangar in late 2013. The club currently shares its home games between Docklands Stadium and the Melbourne Cricket Ground. Andrew McGrath serves as the club captain as of 2026. Essendon is one of Australia's most successful and prominent football clubs, having won 16 VFL/AFL premierships, which is tied (along with Carlton and Collingwood) for the most of any club in the competition. The club experienced notable golden eras under captain-coach Dick Reynolds in the 1940s and 1950s, and under coach Kevin Sheedy from the 1980s to the early 2000s, cultivating the iconic "Baby Bombers" team in 1993 and recording a historically dominant season in 2000. However, the club has struggled to achieve significant on-field success in the 21st century, having not won a finals match since 2004.
Some argue that drugs being illegal makes them more dangerous for consumers, because the lack of regulation resulting from the supply chains being controlled by a black market of criminals gives them free rein to cut drugs with other (potentially dangerous) substances to increase profits.
Sources: en.wikipedia.org
==== Adipose tissue and metabolism ==== In obesity, white adipose tissue undergoes abnormal hypertrophic growth, leading to hypoxia and systemic inflammation. GLP-1 agonists mitigate this by downregulating lipogenic enzymes such as lipoprotein lipase (LPL) and ANGPTL4. Additionally, they promote the "browning" of energy-storing white adipose tissue into energy-burning brown adipose tissue. This metabolic shift is mediated by the activation of AMPK and SIRT1 pathways, which upregulate uncoupling protein 1 (UCP1) and increase cellular thermogenesis and energy expenditure. Some of the metabolic effects of GLP-1 agonists in rodents are also mediated via increased synthesis of fibroblast growth factor 21. Pharmaceutical companies have developed dual GLP-1/FGF21 receptor agonists.
As shown by Lütge, Pikor, and Ludewig (2021), reticular cells in secondary lymphoid organs are not a single homogeneous group of cells, but instead consist of many subtypes of cells defined by their position in the body and expression of cell markers such as podoplanin and ER-TR7.
== Overdose == Through excessive ingestion, accidental or otherwise, persons may experience overdose symptoms including drowsiness, sedation, blurred vision, slurred speech, somnolence, uncontrollable jerking motions, and anxiety. A very high amount taken is associated with breathing suppression, coma, and possibly death, particularly if combined with alcohol or opioids.
=== Songwriting process === In charge of the basic structure of the songs, Chanut or Thépegnier would then present them in rehearsal, where the other band members would develop them through a "more organic" process. Toufouti usually writes the lyrics after receiving the instrumentals. Chanut said in 2015 that he "validates his lyrics so that they totally align with the band's concept". Toufouti writes his lyrics in English for convenience. According to him, it would be more difficult in French, because of the risk of falling into excess and clichés. Furthermore, according to Chanut, the inherent fluidity of English is better suited to metal music, whereas certain French consonants are more abrupt. He added that most of the bands they listen to sing in English. Conversely, Hangman's Chair enjoys using French album or song titles for their sonority. Chanut and Thépegnier had to adapt to periods of lockdown while the rehearsal space remained closed for more than a year. They were both able to exchange ideas, as Thépegnier had his home studio under construction and Chanut had his own audio workstation. They were also able to rehearse remotely without audio latency thanks to the beta version of the NuCorder software, designed by Caste. The drum patterns that would later appear on A Loner were influenced by Thépegnier's use of an electronic drum kit during these remote songwriting sessions. From the album A Loner onwards, Chanut felt the need to write lyrics, even though the roles assigned to composing the "skeletons" of the songs remained the same.
Kipa-Williams thought it would be good to have a character that was not "a player" and instead he was shown wanting a committed relationship. Kipa-Williams gave viewers hope of a reconciliation for Ari and Mac, saying "I think there's always a chance for rekindling relationships. Mack has become quite hurt from it all though." Kipa-Williams said events surrounding the break-up would be "heartbreaking". He predicted tears would be shed and was interested in the audience reaction, adding "something happens that almost rips everyone apart..." Writers scripted a pregnancy for Mac, which she keeps secret from Ari as she decides whether or not to have an abortion. The decision is taken out of her hand when she suffers an ectopic pregnancy and miscarries. Mac returns to work at Salt, but when Ari turns up with Mia and attempts to talk to her, Mac cannot face being in the same room as him. Weir said it was "too painful" for Mac, who is "rattled" by his presence. Weir also said that Mac is feeling confused and abandoned by Ari. Shortly after, Mac collapses and Tane takes her to the hospital, where Ari, who has learned the truth about the pregnancy, comforts her as she cries in his arms.
Sources: en.wikipedia.org
It is a synthetic peptide of 31 amino acids, built to resemble the natural incretin hormone GLP-1. Because of its size and composition it is handled analytically like other therapeutic peptides, using chromatographic and mass spectrometric methods rather than the techniques typical of small organic drugs.
The substitution at position 8 removes the site recognised by dipeptidyl peptidase-4, the enzyme that destroys the native hormone within minutes. The linked lipophilic chain then binds circulating albumin, which further limits access by degradative enzymes and reduces renal loss. Together these features lengthen the effective circulation time considerably.
It acts at the glucagon-like peptide-1 receptor, a G protein-coupled receptor that signals mainly through cyclic AMP. Activation is glucose dependent, meaning insulin release is stimulated more strongly when blood glucose is already elevated. Other tissues carrying the same receptor respond as well, which explains effects beyond glucose control.
Native GLP-1 is degraded within minutes by dipeptidyl peptidase-4 and cleared quickly. Semaglutide carries a position 8 substitution that blocks that cleavage and a fatty diacid chain that binds albumin. Together these changes extend its circulating half-life to about one week.